Synbiotic (Lactobacillus rhamnosus+Lactobacillus acidophilus+inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague'Dawley rats: A long-term study

European Journal of Cancer Prevention

Volumn 23, Issue 6, 2014, Pages 550-559

  Verma, Angela ^a   Shukla, Geeta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Colon cancer; Oxidative stress; Probiotics; Synbiotics; Tumor

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INULIN; MALONALDEHYDE; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE; SYNBIOTIC AGENT; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; COLON CARCINOGENESIS; COLON INJURY; CONTROLLED STUDY; FOLLOW UP; GOBLET CELL; GROWTH RATE; HISTOPATHOLOGY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; LIPID PEROXIDATION; MALE; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; ANIMAL; CARCINOGENESIS; CHEMICALLY INDUCED; COLON; COLONIC NEOPLASMS; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; TIME;

1,2-DIMETHYLHYDRAZINE; ANIMALS; CARCINOGENESIS; CARCINOGENS; COLON; COLONIC NEOPLASMS; INULIN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SYNBIOTICS; TIME FACTORS;

EID: 84914685720     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000054     Document Type: Article

References (54)

1. Aguilar-Delfin I, López-Barrera F, Hernández-Muñoz R (1996). Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CC14 administration. Hepatology 24:657-662.
2. Ahotupa MM, Saxelin M, Korpela R (1996). Antioxidative properties of Lactobacillus GG. Nutr Today 31:51S-52S.
3. American Cancer Soci ety (2011). Colorectal Cancer Facts & Figures 2011-2013. Atlanta, Ga: American Cancer Society.
4. Augeron C, Laboisse CL (1984). Emergence of permanently differentiated cell clones in a human colonic cancer cell li ne in culture after treatment with sodium butyrate. Cancer Res 44:3961-3969.
5. Babbs CF 1990 Free radicals and the etiology of colon cancer Free Radic Biol Med 8 191-200.
6. Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G (1995). Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16:245-252.
7. Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G (1997). Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 28:93-99.
8. Bogdanov IG, Dalev PG, Gurevich AI, Kolosov MN, Malékova VP, Plemyannikova LA, Sorokina IB (1975). Antitumour glycopeptides from Lactobacillus bulgaricus cell wall. FEBS Lett 57:259-261.
9. Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR (1993). Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 53: 4230-4237.
10. Carroll IM, Andrus JM, Bruno-Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS (2007). Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dism utase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293: G729-G738.
11. Clairborne A (1985). Catalase activity. In: Greenwald RA, editor. Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida: CRC Press. pp. 283-284.
12. Corrales F, Giménez A, Alvarez L, Caballería J, Pajares MA, Andreu H, et al. (1992). S-adenosylmethionine treatment prevents carbon tetrachlorideinduced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 16:1022-1027.
13. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. (2010). Colorectal cancer. Lancet 375:1030-1047.
14. Ellman GL (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
15. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
16. Goyal N, Rishi P, Shu kla G (2013). Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study. World J Microbiol Biotechnol 29:1049-1057.
17. Greenberg ER, Bar on JA, Tosteson TD, Freeman DH Jr., Beck GJ, Bond JH, et al. (1994). A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331:141-147.
18. Hawrelak JA, Whitten DL, Myers SP (2005). Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 72:51-56.
19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
20. Kono Y (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189-195.
21. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. (2008). Lon g-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, doubleblind, placebo-controlled trial. Pediatrics 122:8-12.
22. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, Kilk A (2002). Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 72:215-224.
23. Kumar RS, Kanmani P, Yuvaraj N, Paari KA, Pattukumar V, Thirunavukkarasu C, Arul V (2012). Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechno l 166:620-631.
24. Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP (2010). Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcin ogenesis 31:246-251.
25. Lin MY, Chang FJ (2000). Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 45:1617-1622.
26. Liong MT (2008). Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int J Mol Sci 9:854-863.
27. Loft S, Møller P, Cooke MS, Rozalski R, Olinski R (2008). Antioxidant vitamins and cancer risk: is oxidative damage to DNA a relevant biomarker? Eur J Nutr 47 (Suppl 2):19-28.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
29. Mena S, Ortega A, Estrela JM (2009). Oxidative stress in environmentalinduced carcinogenesis. Mutat Res 674:36-44.
30. Mercenier A, Pavan S, Pot B (2003). Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 9:175-191.
31. Mukai T, Toba T, Itoh T, Adachi S (1990). Structural investigation of the capsular polysaccharide from Lactobacillus kefiranofaciens K1. Carbohydr Res 204:227-232.
32. Musenga A, Mandrioli R, Bonifazi P, Kenndler E, Pompei A, Raggi MA (2007 ). Sensitive and selective determination of glutathione in probiotic bacteria by capillary electrophoresis-laser induced fluorescence. Anal Bioanal Chem 387:917-924.
33. Nakajima H, Toyoda S (1990). A novel phosphopolysaccharide from slimeforming Lactococcus lactis subsp. cremoris SBT0495. J Dairy Sci 73:1472-1477.
34. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, et al. (2006). Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis 21:737-746.
35. P erdigón G, Fuller R, Raya R (2001). Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2:27-42.
36. Per͉ e M (2013). Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Intl 2013:725710.
37. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. (2007). Dietary synbiotics reduce cancer risk factors in polypect omized and colon cancer patients. Am J Clin Nutr 85:488-496.
38. Rainis T, Maor I, Lanir A, Shnizer S, Lavy A (2007). Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 52:526-530.
39. Reddy GV, Friend BA, Shahani KM, Farmer RE (1983). Antitumour activity of yogurt components. J Food Prot 46:8-11.
40. Regöly-Mé rei A, Bereczky M, Arató G, Telek G, Pallai Z, Lugasi A, Antal M (2007). Nutritional and antioxidant status of colorectal cancer patients. Orv Hetil 148:1505-1509.
41. Ries LAG, Melbert D, Krapcho M, S tinchcomb DG, Howlader N, Horner MJ, et al. (2008). SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute 2008; http://seer.cancer.gov/csr/1975-2005/, based on November 2007 SEER data s ubmission, posted to the SEER website, 2008.
42. Riordan SM, Skinner NA, McIver CJ, Liu Q, Bengmark S, Bihari D (2007). Synbiotic-associated improvement in liver function in cirrhotic patients: relation to ch anges in circulating cytokine messenger RNA and protein levels. Microb Ecol Health Dis 19:7-16.
43. Rosignoli P, Fabiani R, De Bartolomeo A, Spinozzi F, Agea E, Pelli MA, Morozzi G (2001). Prote ctive activity of butyrate on hydrogen peroxideinduced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 22:1675-1680.
44. Sengottuvelan M, Viswanathan P, Nalini N (2006). Chemoprev entive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27:1038-1046.
45. Shukla G, Sidhu RK, Ver ma A (2012). Restoration of anthropometric, biochemical and histopathological alterations by Lactobacillus casei supplementation in Giardia intestinalis infected renourished BALB/c mice. Antonie Van Leeuwenhoek 102:61-72.
46. Shukla G, Kaur H, Sharma L (2013). Comparative therapeutic effect of probiotic Lactobacillus casei alone and in conjunction with antiprotozoal drugs in murine giardiasis. Parasitol Res 112:2143-2149.
47. Smith RA, Cokkinides V, Brawley OW (2012). Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin[Epub ah ead of print].
48. Verma A,Shukla G (2013a Administration of prebiotic inulin suppresses 1,2 dimethylhydrazine dihydrochloride induced procarcinogenic biomarkers fecal enzymes and preneoplastic lesions in early colon carcinogenesis in Sprague Dawley rats J Funct Foods 5 991-996.
49. Verma A, Shukla G (2013b). Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH induced procarcinogenic fecal enzymes and preneoplastic ab errant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer 65:84-91.
50. Wendel A (1980). Enzymatic basis of detoxication. 1: NY, USA: Academic Press. pp. 333-353.
51. Whitehead RH, Young GP, Bhathal PS (1986). Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27:1457-1463.
52. Wills ED (1966). Mechanism of lipid peroxidation formation in animal tissues. Biochem J 99:667-676.
53. World Health Organization (2008). The global burden of disease: 2004 update. Geneva: World Health Organization.
54. Yano S, Tierney DF (1989). Butyrate increases catalase activity and protects rat pulmonary artery smooth muscle cells against hyperoxia. Biochem Biophys Res Commun 164:1143-1148.